We advised the placement agents on the private placement of common stock

Davis Polk advised the placement agents, in connection with Recursion Pharmaceuticals’ $150 million private placement of common stock.

Recursion Pharmaceuticals is a clinical-stage biotechnology company industrializing drug discovery by decoding biology. Recursion is headquartered in Salt Lake City, Utah.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Jonathan Bye and Henry Hawkins. Partner Frank J. Azzopardi and associates S. Dream Montgomery and Alexis N. Wallace provided intellectual property advice. The tax team included partner Michael Farber and associate Charles Collier. Members of the Davis Polk team are based in the Northern California and New York offices.